Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1811)	6/19/2007 1:25:05 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

ACEL Is starting to move up after finding support at the $2.08 level. bigcharts.marketwatch.com It doesn't have significant LTD.The short position increased 43% in the last month.Its ONCONASE is in PIIIb for mesothelioma, of which there are some cases around in spite of the cut down on asbestos use. It also has AC-03-636 in which it is collaborating with Novartis for treatment of dengue & is also working on a fusion protein for NHL. It seems the R/R is OK as long as the stock can hold above the $2 level bigcharts.marketwatch.com Tha Apr-Jun double top in 2004 was at the $10 level. (In 2004 its loss was $0.17/shr up from the $0.10/shr in 2003 <g>) bigcharts.marketwatch.com Bernard

To: Jibacoa who wrote (1811)	1/7/2008 1:39:48 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

ALTH Is up 15.66% bigcharts.marketwatch.com It announced today the initiation of patient enrollment in a PIIb, comparing PDX ( and Tarceva in patients with Stage IIIB/IV NSCLC whith Hx of smoking & failure of prior treatment with at least one platinum-based chemo. The stock needs to close above its Dec7 H of $7.52 before it can test its Feb H at $8.54 bigcharts.marketwatch.com The EL for 2007 & 2008 are around $0.60 vs. $0.53 in 2006. ALTH has no significant LTD, the insiders hold > 35% & the short ratio is around 13x its ADV, Bernard